Men’s Peer Support Group
Thursday 16 April 2026, 7.00pm - 8.30pm - via Zoom - Come and join Mark Baxter and the group for our latest Men's Peer Support Group online social catch up.
Search
Search results
Manchester Local Peer Support Group
Saturday 9 May 2026, 12.30pm - 6.00pm - In-person - You are invited to join Rachael and the group for their latest in-person get together at The Freemount bar in Manchester followed by the Barrel of Laughs matinee show at the Frog & Bucket Comedy Club.
New Chair of Trustees
We are delighted to welcome Kathy Evans as our new Chair of Trustees.
‘Talking’ Home & Garden Peer Support Group
Tuesday 14 April 2026, 7.00pm - 8.00pm - via Zoom - Please come and join facilitators Brian Coates & Steve Cox for our first meeting of 2026 where we are delighted to welcome our guest speakers and avid gardeners, John Huxley & Scott Racine.
RP Awareness Month – Paul’s Story
During RP awareness month, Paul Bacon has shared how his diagnosis has impacted his life and shared messages about how non visually impaired people can support those living with inherited sight loss. To learn more about inherited sight loss please take the time to read Paul's story.
Meet our supporters: William Taylor
Fundraising for Retina UK means a lot to me - both my dad and my nephew have been affected by inherited sight-loss, and I've seen first-hand the incredible work this charity does.
Meet a researcher: Chloe Brotherton
As part of our aim to nurture young scientists, we are very pleased to introduce one of our new PhD students as part of a co-funding agreement with the Macular Society.
Slowing sight loss in stargardts: Ocugen’s gene therapy trial offers promising early results
Ocugen’s gene therapy candidate, OCU410ST, is an experimental treatment designed to slow vision loss in Stargardt disease, an inherited retinal disease (IRD) with no approved therapies currently.
Gene therapy treatment Luxturna accepted for use in Scotland
Retina UK is delighted that the Scottish Medicines Consortium (SMC) has accepted the gene therapy Luxturna (voretigene neparvovec) for ongoing use by the NHS in Scotland.
Johnson & Johnson gene therapy update – What happens now?
The latest research news from Retina UK.